Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema

Ann Allergy Asthma Immunol. 2016 May;116(5):472-3. doi: 10.1016/j.anai.2016.03.003. Epub 2016 Mar 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angioedema / drug therapy*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Autoantibodies / blood
  • Complement System Proteins / analysis
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / diagnosis
  • Lymphoma, B-Cell, Marginal Zone / drug therapy*
  • Male
  • Rituximab / therapeutic use*
  • Splenic Neoplasms / diagnosis
  • Splenic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Immunological
  • Autoantibodies
  • Rituximab
  • Complement System Proteins

Supplementary concepts

  • Acquired angioedema